What is Mikroscan Technologies?
Mikroscan Technologies specializes in digital pathology, telemicroscopy, and image archive services. The company provides affordable and portable solutions designed to enhance diagnostic efficiency and accuracy for pathologists. By enabling remote subspecialty expertise and overcoming geographical barriers, Mikroscan's innovative systems, including the SL5 dual-mode system and L5 live telemicroscopy system, aim to improve patient care and support the broader pathology community.
How much funding has Mikroscan Technologies raised?
Mikroscan Technologies has raised a total of $6.6M across 3 funding rounds:
Private Equity
$6.2M
Debt
$150K
Debt
$285K
Private Equity (2015): $6.2M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $285K supported by PPP
Key Investors in Mikroscan Technologies
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Mikroscan Technologies?
The recent major strategic investment of $285K positions Mikroscan Technologies for significant expansion and further development in the digital pathology market. This enterprise-level funding suggests a focus on scaling operations, enhancing technological capabilities, and potentially broadening market reach. The company's trajectory indicates a commitment to advancing diagnostic accuracy and accessibility in healthcare.
See full Mikroscan Technologies company page
